12:00 AM
 | 
Jul 23, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

CellCept mycophenolate mofetil regulatory update

FDA approved an updated label for Roche's CellCept mycophenolate mofetil to include a black box warning on embryofetal toxicity, malignancies and serious infections. The agency also added a warning stating that the use of CellCept during pregnancy is associated with an increased risk of...

Read the full 197 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >